Can Vitamin B12 Assist the Internalization of Antisense LNA Oligonucleotides into Bacteria?
- PMID: 33916701
- PMCID: PMC8065541
- DOI: 10.3390/antibiotics10040379
Can Vitamin B12 Assist the Internalization of Antisense LNA Oligonucleotides into Bacteria?
Abstract
The emergence of bacterial resistance to traditional small-molecule antibiotics is fueling the search for innovative strategies to treat infections. Inhibiting the expression of essential bacterial genes using antisense oligonucleotides (ASOs), particularly composed of nucleic acid mimics (NAMs), has emerged as a promising strategy. However, their efficiency depends on their association with vectors that can translocate the bacterial envelope. Vitamin B12 is among the largest molecules known to be taken up by bacteria and has very recently started to gain interest as a trojan-horse vector. Gapmers and steric blockers were evaluated as ASOs against Escherichia coli (E. coli). Both ASOs were successfully conjugated to B12 by copper-free azide-alkyne click-chemistry. The biological effect of the two conjugates was evaluated together with their intracellular localization in E. coli. Although not only B12 but also both B12-ASO conjugates interacted strongly with E. coli, they were mostly colocalized with the outer membrane. Only 6-9% were detected in the cytosol, which showed to be insufficient for bacterial growth inhibition. These results suggest that the internalization of B12-ASO conjugates is strongly affected by the low uptake rate of the B12 in E. coli and that further studies are needed before considering this strategy against biofilms in vivo.
Keywords: 2′OMe; LNA; antibacterial drug; antisense oligonucleotides; nucleic acid mimics; vitamin B12.
Conflict of interest statement
The authors declare no conflict of interest.
Figures






Similar articles
-
Vitamin B12 - Peptide Nucleic Acid Conjugates.Methods Mol Biol. 2021;2355:65-82. doi: 10.1007/978-1-0716-1617-8_7. Methods Mol Biol. 2021. PMID: 34386951
-
An Investigation into the Potential of Targeting Escherichia coli rne mRNA with Locked Nucleic Acid (LNA) Gapmers as an Antibacterial Strategy.Molecules. 2021 Jun 4;26(11):3414. doi: 10.3390/molecules26113414. Molecules. 2021. PMID: 34200016 Free PMC article.
-
Vitamin B12 transports modified RNA into E. coli and S. Typhimurium cells.Chem Commun (Camb). 2019 Jan 15;55(6):763-766. doi: 10.1039/c8cc05064c. Chem Commun (Camb). 2019. PMID: 30480264
-
Advances in the delivery of antisense oligonucleotides for combating bacterial infectious diseases.Nanomedicine. 2018 Apr;14(3):745-758. doi: 10.1016/j.nano.2017.12.026. Epub 2018 Jan 16. Nanomedicine. 2018. PMID: 29341934 Review.
-
Targeting FMN, TPP, SAM-I, and glmS Riboswitches with Chimeric Antisense Oligonucleotides for Completely Rational Antibacterial Drug Development.Antibiotics (Basel). 2023 Nov 8;12(11):1607. doi: 10.3390/antibiotics12111607. Antibiotics (Basel). 2023. PMID: 37998809 Free PMC article. Review.
Cited by
-
Bioinformatics and Genomic Analyses of the Suitability of Eight Riboswitches for Antibacterial Drug Targets.Antibiotics (Basel). 2022 Aug 31;11(9):1177. doi: 10.3390/antibiotics11091177. Antibiotics (Basel). 2022. PMID: 36139956 Free PMC article.
-
New Insights on Biofilm Antimicrobial Strategies, 2nd Volume.Antibiotics (Basel). 2022 Jul 7;11(7):908. doi: 10.3390/antibiotics11070908. Antibiotics (Basel). 2022. PMID: 35884162 Free PMC article.
-
A comparative analysis of peptide-delivered antisense antibiotics using diverse nucleotide mimics.RNA. 2024 May 16;30(6):624-643. doi: 10.1261/rna.079969.124. RNA. 2024. PMID: 38413166 Free PMC article.
-
Chemical strategies for antisense antibiotics.Chem Soc Rev. 2024 Nov 25;53(23):11303-11320. doi: 10.1039/d4cs00238e. Chem Soc Rev. 2024. PMID: 39436264 Free PMC article. Review.
-
Promising strategies employing nucleic acids as antimicrobial drugs.Mol Ther Nucleic Acids. 2024 Jan 18;35(1):102122. doi: 10.1016/j.omtn.2024.102122. eCollection 2024 Mar 12. Mol Ther Nucleic Acids. 2024. PMID: 38333674 Free PMC article. Review.
References
-
- WHO . The Evolving Threat of Antimicrobial Resistance: Options for Action. World Health Organization; Geneva, Switzerland: 2012.
-
- Bai H., You Y., Yan H., Meng J., Xue X., Hou Z., Zhou Y., Ma X., Sang G., Luo X. Antisense inhibition of gene expression and growth in gram-negative bacteria by cell-penetrating peptide conjugates of peptide nucleic acids targeted to rpoD gene. Biomaterials. 2012;33:659–667. doi: 10.1016/j.biomaterials.2011.09.075. - DOI - PubMed
-
- Wengel J. Synthesis of 3 ‘-C-and 4 ‘-C-branched oligodeoxynucleotides and the development of locked nucleic acid (LNA) Acc. Chem. Res. 1999;32:301–310. doi: 10.1021/ar980051p. - DOI
Grants and funding
- SFRH/BD/118018/2016/Fundação para a Ciência e a Tecnologia
- Project UID/EQU/00511/2019 - Laboratory for Process Engineering, Environment, Biotechnology and Energy - LEPABE/FCT/MCTES (PIDDAC)
- 810685/European Union's Horizon 2020 research and innovation program
- Project "LEPABE-2-ECO-INNOVATION" - NORTE-01-0145-FEDER-000005/Norte Portugal Regional Operational Programme (NORTE 2020), under PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF)
- VKR18333/VILLUM FONDEN
LinkOut - more resources
Full Text Sources
Other Literature Sources